$ALNY
ALNYLAM PHARMACEUTICALS, INC.

2018 Q2 Form 10-Q Financial Statement

#000156459018018696 Filed on August 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $29.91M $15.93M
YoY Change 87.72% 83.13%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $84.68M $45.80M
YoY Change 84.89% 154.44%
% of Gross Profit
Research & Development $137.6M $90.60M
YoY Change 51.86% 8.93%
% of Gross Profit
Depreciation & Amortization $2.200M $3.100M
YoY Change -29.03% -22.5%
% of Gross Profit
Operating Expenses $222.3M $136.4M
YoY Change 62.94% 34.84%
Operating Profit -$192.4M
YoY Change
Interest Expense $6.100M $2.600M
YoY Change 134.62% 23.81%
% of Operating Profit
Other Income/Expense, Net $28.87M -$500.0K
YoY Change -5874.6% -121.54%
Pretax Income -$163.5M -$118.4M
YoY Change 38.05% 31.39%
Income Tax $79.00K
% Of Pretax Income
Net Earnings -$163.6M -$118.4M
YoY Change 38.12% 31.39%
Net Earnings / Revenue -546.9% -743.28%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.628M -$1.344M
COMMON SHARES
Basic Shares Outstanding 86.19M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.448B $923.3M
YoY Change 56.8% 9.52%
Cash & Equivalents $361.5M $408.7M
Short-Term Investments $1.086B $514.6M
Other Short-Term Assets $51.90M $22.00M
YoY Change 135.91% -0.9%
Inventory
Prepaid Expenses
Receivables $3.000M $15.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.503B $960.7M
YoY Change 56.41% 8.18%
LONG-TERM ASSETS
Property, Plant & Equipment $227.8M $147.5M
YoY Change 54.47% 166.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $174.6M
YoY Change -100.0% -39.21%
Other Assets $14.17M $151.5M
YoY Change -90.65% 10199.12%
Total Long-Term Assets $286.8M $473.6M
YoY Change -39.44% -4.15%
TOTAL ASSETS
Total Short-Term Assets $1.503B $960.7M
Total Long-Term Assets $286.8M $473.6M
Total Assets $1.789B $1.434B
YoY Change 24.76% 3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.99M $23.20M
YoY Change -48.33% 80.91%
Accrued Expenses $89.87M $43.80M
YoY Change 105.18% 16.64%
Deferred Revenue $9.161M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $113.7M $108.7M
YoY Change 4.56% 54.02%
LONG-TERM LIABILITIES
Long-Term Debt $30.00M $150.0M
YoY Change -80.0% 0.0%
Other Long-Term Liabilities $4.186M $52.60M
YoY Change -92.04% 2860.05%
Total Long-Term Liabilities $4.186M $202.6M
YoY Change -97.93% 11301.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $113.7M $108.7M
Total Long-Term Liabilities $4.186M $202.6M
Total Liabilities $168.6M $311.3M
YoY Change -45.84% 9.74%
SHAREHOLDERS EQUITY
Retained Earnings -$2.384B
YoY Change
Common Stock $4.039B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.621B $1.123B
YoY Change
Total Liabilities & Shareholders Equity $1.789B $1.434B
YoY Change 24.76% 3.77%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$163.6M -$118.4M
YoY Change 38.12% 31.39%
Depreciation, Depletion And Amortization $2.200M $3.100M
YoY Change -29.03% -22.5%
Cash From Operating Activities -$102.7M -$81.10M
YoY Change 26.63% 15.53%
INVESTING ACTIVITIES
Capital Expenditures -$22.70M -$21.60M
YoY Change 5.09% 71.43%
Acquisitions
YoY Change
Other Investing Activities $85.40M -$46.00M
YoY Change -285.65% 44.65%
Cash From Investing Activities $62.60M -$67.70M
YoY Change -192.47% 52.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.600M 386.3M
YoY Change -98.55% 150.36%
NET CHANGE
Cash From Operating Activities -102.7M -81.10M
Cash From Investing Activities 62.60M -67.70M
Cash From Financing Activities 5.600M 386.3M
Net Change In Cash -34.50M 237.5M
YoY Change -114.53% 496.73%
FREE CASH FLOW
Cash From Operating Activities -$102.7M -$81.10M
Capital Expenditures -$22.70M -$21.60M
Free Cash Flow -$80.00M -$59.50M
YoY Change 34.45% 3.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
12044000
CY2018Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9161000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41705000
CY2018Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4522000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
43075000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84679000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
222261000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
227839000
CY2018Q2 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
44825000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14166000
CY2018Q2 us-gaap Assets
Assets
1789389000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11988000
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89867000
CY2018Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
2643000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
113659000
CY2018Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
16220000
CY2018Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
30000000
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4186000
CY2018Q2 us-gaap Liabilities
Liabilities
168587000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
1005000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4037853000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33807000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2384249000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1620802000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1789389000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100569034
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100569034
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-163481000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-192354000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-225710000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-118420000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-304757000
CY2018Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
20564000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
20564000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1275000
alny Marketable Equity Securities Unrealized Gain Loss
MarketableEquitySecuritiesUnrealizedGainLoss
2044000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
14825000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2326000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
642787000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
1074000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-163560000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-118420000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.63
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87068000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
626000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2412000
CY2017Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-345000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1894000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-118551000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-304148000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-226228000
us-gaap Profit Loss
ProfitLoss
-304774000
us-gaap Profit Loss
ProfitLoss
-225710000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
5417000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
6066000
us-gaap Share Based Compensation
ShareBasedCompensation
41825000
us-gaap Share Based Compensation
ShareBasedCompensation
39747000
alny Non Cash Gain On Litigation Settlement
NonCashGainOnLitigationSettlement
10000000
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-1894000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
608000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-4480000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-31041000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7929000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21261000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
198000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9735000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8326000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
7261000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-3404000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2887000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1059000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-258351000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-181379000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43965000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57803000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
237184000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
629384000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
302392000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72193000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7405000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
47735000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12644000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
355150000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
21381000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
632000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
147000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47103000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
389028000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-283441000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
215054000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
646832000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
195088000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
363391000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
410142000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
408671000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1934000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1471000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p></div>
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12944000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12544000
CY2017Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5000000
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
71.87
CY2017Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
355200000
CY2017Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4200000
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-145600000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
alny Reclassification Adjustment From Aoci For Available For Sale Debt Securities
ReclassificationAdjustmentFromAOCIForAvailableForSaleDebtSecurities
0
alny Reclassification Adjustment From Aoci For Available For Sale Debt Securities
ReclassificationAdjustmentFromAOCIForAvailableForSaleDebtSecurities
0
alny Investments Classified As Cash And Cash Equivalent Original Maturities
InvestmentsClassifiedAsCashAndCashEquivalentOriginalMaturities
P90D
alny Investment Maturity Period Minimum
InvestmentMaturityPeriodMinimum
P90D
CY2018Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29907000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15932000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51806000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34892000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11996000
CY2018Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13683000
CY2018Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16570000
CY2018Q2 alny Litigation Settlement Common Stock Issuable From Other Party
LitigationSettlementCommonStockIssuableFromOtherParty
983208
alny Tax Cuts And Jobs Act Of2017 Measurement Period Adjustment Income Tax Expense Benefit
TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
-800000
CY2018Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1075180000
CY2018Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2018Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1022000
CY2018Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1074165000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1653000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1060817000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1059176000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1075180000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1074165000

Files In Submission

Name View Source Status
0001564590-18-018696-index-headers.html Edgar Link pending
0001564590-18-018696-index.html Edgar Link pending
0001564590-18-018696.txt Edgar Link pending
0001564590-18-018696-xbrl.zip Edgar Link pending
alny-10q_20180630.htm Edgar Link pending
alny-20180630.xml Edgar Link completed
alny-20180630.xsd Edgar Link pending
alny-20180630_cal.xml Edgar Link unprocessable
alny-20180630_def.xml Edgar Link unprocessable
alny-20180630_lab.xml Edgar Link unprocessable
alny-20180630_pre.xml Edgar Link unprocessable
alny-ex101_195.htm Edgar Link pending
alny-ex102_103.htm Edgar Link pending
alny-ex311_12.htm Edgar Link pending
alny-ex312_7.htm Edgar Link pending
alny-ex321_8.htm Edgar Link pending
alny-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g5inm2ra3axp000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending